Join the Topix community today: 

Sign Up

 | 

Sign In

Become a Topix Editor today!

topix
Advertisment

Forum & Polls

News

NewsWire

RSS icon mobile icon Add headlines icon

Schering Plough News

News on Schering Plough continually updated from thousands of sources around the net.

Yesterday | Rehab Management

Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C...

It is the leading cause of cirrhosis and liver cancer, and the number one reason for liver transplants in . via Rehab Management

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, San Diego, CA

Tuesday May 13 | The Jersey Journal

Solar system in PPL's plans

“Continued competition in the electric market will help fuel the growth of clean energy sources and make it possible for more projects like this to become a reality”

PPL Corp. plans to build and design a rooftop solar system for New Jersey-based pharmaceutical company Schering-Plough Corp. via The Jersey Journal

Comment?

Related Topix: Summit, NJ, PPL Corp, Energy, Biotech, Medicine, Healthcare Industry, Science / Technology, Alternative Energy

Monday May 12 | Pennlive.com

PPL to develop largest rooftop solar energy system

“Solar energy technology helps reduce clients' operating costs by using a reliable and renewable power source to meet their energy needs”

Posted by Express-Times staff May 12, 2008 09:40AM PPL Renewable Energy announced plans today to design, construct and operate a 1.7-megawatt solar system for Schering-Plough Corporation in Summit, N.J. When ... via Pennlive.com

Comment?

Related Topix: Summit, NJ, Science / Technology, Alternative Energy, Biotech, Medicine, Healthcare Industry

Sunday May 11 | ISIL Channels

Stupak: Drugmakers need to rein in ads

Posted: May 8th, 2008 by Steve Trinward "Pharmaceutical companies need to be more responsible in touting products to consumers or else face tighter controls from Congress, a top U.S. Democratic lawmaker said on ... via ISIL Channels

Comment?

Related Topix: US News, Biotech, Medicine, Healthcare Industry

Friday May 9 | Med Ad News

Schering-Plough Schedules Webcast for Annual Meeting of Shareholders

KENILWORTH, N.J., May 09, 2008 /PRNewswire-FirstCall/ -- Schering-Plough Corporation will hold its Annual Meeting of Shareholders Friday, May 16, 2008, in Memphis, Tenn. via Med Ad News

Comment?

Related Topix: Kenilworth, NJ, Biotech, Medicine, Healthcare Industry

Friday May 9 | Med Ad News

Overview of Asenapine Data from Olympia Trial Program Presented at...

“Therefore, new therapies that are both effective and well-tolerated would be welcome additions to the treatment options currently available for improving patient care.”

Schering-Plough Corporation today announced that an overview of asenapine clinical trials from the Olympia program was presented at the 161st Annual Meeting of the American Psychiatric Association in ... via Med Ad News

Comment?

Related Topix: Law, Biotech, Medicine, Healthcare Industry, Schizophrenia, Health, Zyprexa, Zydis, Olanzapine (generic), Medication

Thursday May 8 | Daily Breeze

Drug companies defend TV ads before Congress

Some of the nation's largest pharmaceutical companies defended their TV advertisements Thursday from Democrats calling for tougher restrictions on what they call misleading marketing. via Daily Breeze

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Johnson and Johnson

Wednesday May 7 | Earth Times

First Animals are Vaccinated Against Bluetongue

Cattle at Bixley Farms in Norfolk were today the first animals in the country to be vaccinated against Bluetongue serotype 8 as over one million doses are delivered for animals in the Protection Zone on the ... via Earth Times

Comment?

Related Topix: Agriculture, Science, Biotech, Medicine, Healthcare Industry

Monday May 5 | Forbes.com

Investors Breathe Right With Sepracor

“The acquisition of Oryx fulfills a long-standing corporate objective of developing a commercial footprint in the strategically important Canadian pharmaceutical market”

Investors of Sepracor were breathing easy on Thursday after the company beat the Street on earnings per share and settled a pesky lawsuit, but the quarter wasn't without its hiccups. via Forbes.com

Comment?

Related Topix: Biotech, Sepracor, Medicine, Healthcare Industry, Financial Markets

Saturday May 3 | The Motley Fool

Sepracor Diversifies to Sleep Better

Let's run through the numbers real quickly. Revenue was down 2.1% year over year because sleep aid Lunesta -- down 8% -- continues to receive indirect generic competition from knockoffs of Sanofi-Aventis ' ... via The Motley Fool

Comment?

Related Topix: Biotech, SanofiSynthlabo, Medicine, Healthcare Industry

Schering Plough Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

Become an editor for today!

Edits History

More Schering Plough News

Schering Plough News Archives buttonFind the stories you missed in the Archives.

Schering Plough News Forum buttonJoin the lively discussion in our Forums.

Schering Plough News Wire buttonBrowse continually updated news from the Wire.